Search Results 1861-1870 of 16876 for Residual
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...
About this study. This is a Phase III, randomised, open-label, sponsor-blinded, 3-arm, multicentre, global study assessing the efficacy and safety of ...
Mayo Clinic researchers found a potential way to improve access for patients with end-stage kidney disease to hemodialysis.
ROCHESTER, Minn. — Mayo Clinic researchers have developed a calculation that can help identify moderate aortic stenosis patients at higher risk of dying from ...
Mayo Clinic researchers lead discoveries into many conditions, including cancer, Alzheimer's disease and other forms of dementia, as well as how the brain ...
A recent Mayo Clinic retrospective study shows that cancer practices can integrate telehealth without duplicative care, allowing for a more streamlined ...
The purpose of this study is to collect data related to patients undergoing diagnostic evaluation and treatment of Gastroesophageal Reflux Disease (GERD) and ...
Mayo Clinic researchers resolve a diagnostic odyssey for mother and son featured image. Research ; Mayo Clinic announces transformative $1.9B investment in ...
Rochester, Minn. The purpose of this study is to create a registry of obese patients who have been phenotyped to understand the heterogeneity of obesity. Celiac ...
Researchers in the Regenerative Neurosurgery and Neuro-Oncology Lab are studying live brain tumors to understand the chemical signals that define tumors and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!